Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunmodulation in Patients With HHT

NCT02983253 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT02983253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02983253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunmodulation in Patients With HHT
Lead sponsor
University Hospital, Essen
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
October 31, 2019
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary haemorrhagic telangiectasia (hht)